Nucleic acid and corresponding protein entitled 193P1E1B...

Details Nucleic acid and corresponding protein entitled 193P1E1B... Nucleic acid and corresponding protein entitled 193P1E1B...

2002-12-06

2009-11-10

Yu, Misook (Department: 1642)

Chemistry: analytical and immunological testing

Biospecific ligand binding assay

C436S518000, C435S007230

Reexamination Certificate

active

07615379

ABSTRACT:
A novel gene 0193P1E1B (also designated 193P1E1B) and its encoded protein, and variants thereof, are described wherein 193P1E1B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 193P1E1B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 193P1E1B gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 193P1E1B can be used in active or passive immunization.

REFERENCES:
patent: 5643778 (1997-07-01), Nishikura
patent: 5840839 (1998-11-01), Wang et al.
patent: 1 308 459 (2003-05-01), None
patent: WO98/39446 (1998-09-01), None
patent: WO98/45435 (1998-10-01), None
patent: WO99/06548 (1999-02-01), None
patent: WO99/31236 (1999-06-01), None
patent: WO99/38972 (1999-08-01), None
patent: WO99/58675 (1999-11-01), None
patent: WO00/18916 (2000-04-01), None
patent: WO00/21991 (2000-04-01), None
patent: WO-01/12811 (2001-02-01), None
patent: WO01/22920 (2001-04-01), None
patent: WO01/42302 (2001-06-01), None
patent: WO01/42451 (2001-06-01), None
patent: WO01/60860 (2001-08-01), None
patent: WO-01/90157 (2001-11-01), None
patent: WO02/29086 (2002-04-01), None
patent: WO02/40718 (2002-05-01), None
patent: WO02/48337 (2002-06-01), None
patent: WO02/074961 (2002-09-01), None
patent: WO02/085298 (2002-10-01), None
patent: WO-2004/028479 (2004-04-01), None
Thai et al., (Adv Immunol. 2005;86:113-36, abstract only).
Greenbaum et al. (Genome Biology, 2003, vol. 4, Issue 9, pp. 117.1-117.8).
You et al., Neoplasia. Jun. 2007; 9(6): 464-470.
Alberts et al., Molecular Biology of the Cell, 3rd Edition (1994) p. 465.
Boon, Adv. Can. Res. (1992) 58:177-210.
Bork, Genome Research (2000) 10:398-400.
Bork et al., Trends in Genetics (1996) 12:425-427.
Bowie et al., Science (1990) 247:1306-1310.
Brenner, Trends in Genetics (1999) 15:132-133.
Broder et al., Curr. Opin. Biotechnol. (2000) 11(6):581-585.
Bussenmakers et al., Cancer Res. (1999) 59:5975-5979.
Curti, Crit. Rev. in Oncology/Hematology (1993) 14:29-39.
Doerks et al., Trends in Genetics (1998) 14:248-250.
Ezzell, J. NIH Res. (1995) 7:46-49.
Fu et al., EMBO Journal (1996) 15:4392-4401.
Gura, Science (1997) 278:1041-1042.
Jain, Sci. Am. (1994) 271:58-65.
Lauritzsen et al., International Journal of Cancer (1998) 78:216-222.
McClean and Hill, Eur. J. of Cancer (1993) 29A:2243-2248.
NCBI Accession No. BC013418 (Sep. 4, 2001).
Sarma et al., Journal of Experimental Medicine (1999) 189:811-820.
Scott et al., Nature Genetics (1999) 21:440-443.
Shantz and Pegg, Int. J. of Biochem. and Cell Biol. (1999) 31:107-122.
Sherman et al., Critical Reviews in Immunol. (1998) 18(1-2):47-54.
Skolnick et al., Trends in Biotech. (2000) 18:34-39.
Smith et al., Nature Biotechnology (1997) 15:1222-1223.
Spitler, Cancer Biotherapy (1995) 10:1-3.
Wang et al., J. Biol. Chem. (1997) 272(35):22227-22235.
Benjamini and Leskowitz, Immunology: A Short Course, Second Edition, John Wiley & Sons, Inc. (1993) Ch. 3, pp. 37-45.
International Search Report for PCT/US02/39274, mailed on Oct. 6, 2004, 3 pages.
Ota et al., Nat. Genet. (2004) 36(1):40-45.
Shibata et al., Genome Res. (2000) 10(11):1757-1771.
Database EMBL, EBI accession No. EMBL:BC013418 (2001).
Database EMBL, EBI accession No. EMBL:BG392826 (2001).
Database EMBL, EBI accession No. EMBL:AL561096 (2001).
Database EMBL, EBI accession No. EMBL:AL519504 (2001).
Database EMBL, EBI accession No. EMBL:AK090584 (2002).
Supplementary Partial European Search Report for EP 02797238.9, mailed Oct. 12, 2007, 7 pages.
Hubert et al., PNAS USA (1999) 96(25):14523-14528.
Japanese Office Action for Application No. 2003-551277, mailed on Feb. 15, 2008, 7 pages.
Klein et al., Nature Medicine (1997) 3(4):402-408.
Office Action for European Patent Application No. EP 02 797 238.9, mailed on Jun. 13, 2008, 11 pages.

Affiliated with

Also associated with

Rating

Nucleic acid and corresponding protein entitled 193P1E1B... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid and corresponding protein entitled 193P1E1B..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid and corresponding protein entitled 193P1E1B... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4107823